Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B

Fast Track designation has the potential to facilitate development and accelerate FDA review of imdusiran WARMINSTER, Pa., April 15, 2026 ...
InvestorsHub on MSN

Arbutus shares jump after FDA grants fast track status to hepatitis B therapy

Arbutus Biopharma Corporation (NASDAQ:ABUS) shares climbed 6% on Wednesday after the company revealed it had received Fast ...

Arbutus Biopharma Corporation

View Arbutus Biopharma Corporation ABUS stock quote prices, financial information, real-time forecasts, and company news from CNN.
Investing.com South Africa

Arbutus stock jumps 6% on FDA fast track designation

Arbutus Biopharma Corporation (NASDAQ:ABUS) shares rose 6% Wednesday after the company announced it received Fast Track designation from the U.S. Food and Drug Ad ...
Yahoo Finance

Here’s Why Arbutus (ABUS) Surged in Q3

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Forbes

Roivant Makes $116 Million Investment In Arbutus, Backing Battle With Moderna

Roivant Sciences and Moderna Therapeutics, two of the most highly-funded and controversial companies in the biotechnology world, are headed for a collision course over medical technology. On Monday, ...
FierceBiotech

Arbutus cans early-phase hep B program after 2 healthy people fall ill

Arbutus Biopharma is dumping one of its Roivant-backed programs after two healthy people in a phase 1 study developed acute hepatitis—the very disease the drug was supposed to treat. The company was ...
The Bakersfield Californian

Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic ...

Fast Track designation has the potential to facilitate development and accelerate FDA review of imdusiran WARMINSTER, Pa., April 15, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ...